SIRT1 and Alzheimer disease: Furthermore, miR-135b targets Disrupted-in-Schizophrenia-1, a critical risk factor for neuropsychiatric disorders, as well as sirtuin 1, which has demonstrated neuroprotective effects in AD (Rossi et al., 2014; Li R. et al., 2020; Li et al., 2022).